SAM
APLS

Sectoral Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Sectoral Asset Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,300
Closed -$297K – 88
2024
Q3 		$297K Sell
10,300
-160
-2% -$5.92K 0.18% 76
2024
Q2 		$401K Buy
10,460
+790
+8% +$35.8K 0.16% 73
2024
Q1 		$568K Buy
9,670
+4,450
+85% +$284K 0.22% 67
2023
Q4 		$312K Hold
5,220
– – 0.13% 92
2023
Q3 		$199K Sell
5,220
-138,639
-96% -$6.09M 0.04% 118
2023
Q2 		$13.1M Sell
143,859
-28,631
-17% -$2.47M 2.19% 4
2023
Q1 		$11.4M Buy
172,490
+20,150
+13% +$1.16M 2.19% 7
2022
Q4 		$7.88M Buy
152,340
+28,350
+23% +$1.5M 1.52% 19
2022
Q3 		$8.47M Sell
123,990
-29,260
-19% -$1.73M 1.67% 17
2022
Q2 		$6.93M Buy
153,250
+83,750
+121% +$3.82M 1.4% 22
2022
Q1 		$3.53M Buy
+69,500
New +$3.07M 0.63% 61
2021
Q1 		– Sell
-65,000
Closed -$3.72M – 116
2020
Q4 		$3.72M Buy
+65,000
New +$2.75M 0.26% 74
2020
Q3 		– Sell
-768,609
Closed -$25.1M – 95
2020
Q2 		$25.1M Buy
768,609
+389,686
+103% +$12.5M 2.3% 6
2020
Q1 		$10.2M Sell
378,923
-76,470
-17% -$2.71M 1.95% 17
2019
Q4 		$13.9M Sell
455,393
-541,590
-54% -$15M 2.08% 20
2019
Q3 		$24M Sell
996,983
-492,974
-33% -$13.6M 4.14% 4
2019
Q2 		$37.8M Sell
1,489,957
-237,872
-14% -$4.84M 4.51% 3
2019
Q1 		$33.7M Sell
1,727,829
-440,286
-20% -$6.92M 4.05% 4
2018
Q4 		$28.6M Buy
2,168,115
+129,599
+6% +$1.99M 3.89% 6
2018
Q3 		$36.2M Buy
2,038,516
+295,894
+17% +$5.47M 3.85% 3
2018
Q2 		$38.3M Buy
1,742,622
+94,930
+6% +$2.18M 4.29% 3
2018
Q1 		$36.4M Sell
1,647,692
-104,963
-6% -$2.06M 3.99% 2
2017
Q4 		$38M Buy
+1,752,655
New +$25.8M 4.75% 2

Other funds holding APLS

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sectoral Asset Management's APLS Position: Q4 2024 in Review

Sectoral Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q4 2024, closing a stake of 10,300 shares — an estimated $297K sold.

Sectoral Asset Management first reported a position in APLS in Q4 2017 and held it in 23 quarters. The position peaked at $38.3M in Q2 2018. 260 funds tracked by Wall St. Rank hold APLS as of Q4 2024.

  • Sectoral Asset Management reported no remaining Apellis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 10,300 Apellis Pharmaceuticals shares in Q4 2024, an estimated $297K.
  • Sectoral Asset Management first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 23 quarters.
  • Sectoral Asset Management's Apellis Pharmaceuticals position peaked at $38.3M in Q2 2018.
  • 260 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2024.

Based on Sectoral Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.